Trinity Biotech
TRIB
24 hedge funds and large institutions have $468K invested in Trinity Biotech in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 8 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
14% more funds holding
Funds holding: 21 → 24 (+3)
0.02% less ownership
Funds ownership: 0.02% → 0.01% (-0.02%)
80% less capital invested
Capital invested by funds: $2.3M → $468K (-$1.83M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$52.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$32.8K |
| 3 |
WN
Williams & Novak
Westlake Village,
California
|
+$14.4K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$13.8K |
| 5 |
Two Sigma Investments
New York
|
+$11.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$1.58M |
| 2 |
Renaissance Technologies
New York
|
-$88.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| 4 |
GI
GAMMA Investing
Foster City,
California
|
-$9.99K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.35K |
TRIB Hedge Fund Activity: Q1 2025 in Review
24 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q1 2025, worth a combined $468K — down 80% from $2.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TRIB positions and 4 closed out — a net gain of 3 holders — while 0 added to existing stakes and 8 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $52.3K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.58M sold.
- 24 institutional investors held Trinity Biotech (TRIB) as of Q1 2025, up from 21 in Q4 2024.
- Funds reported $468K of Trinity Biotech stock for Q1 2025, down 80% quarter-over-quarter.
- 7 funds opened new Trinity Biotech positions in Q1 2025 and 4 closed out, a net change of +3 holders.
- The largest Trinity Biotech buyer in Q1 2025 was HRT Financial, an estimated $52.3K added.
- The largest Trinity Biotech seller in Q1 2025 was Perceptive Advisors, an estimated $1.58M sold.
Based on aggregated 13F filings for Q1 2025.